Advertisement

ADVERTISEMENT

comparative effectiveness

What is the Standard First-Line Therapy for Advanced HCC?
Quiz
What is the Standard First-Line Therapy for Advanced HCC?
12/01/2020
12/01/2020
Journal of Clinical Pathways
News
Comparative Effectiveness of Digital Breast Tomosynthesis vs Digital Mammography in Community Practice
09/03/2020
09/03/2020
Journal of Clinical Pathways
News
Cryoablation vs Surgery for Early-Stage Kidney Cancer
07/01/2020
A minimally invasive procedure is as effective as surgery for treating early-stage kidney cancer, according to 10-year survival data published in Radiology (online June 9, 2020;...
A minimally invasive procedure is as effective as surgery for treating early-stage kidney cancer, according to 10-year survival data published in Radiology (online June 9, 2020;...
A...
07/01/2020
Journal of Clinical Pathways
News
Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer
06/23/2020
Among patients with early-stage cervical cancer, minimally invasive radical hysterectomy is associated with an elevated risk of recurrence and death compared with open radical hysterectomy, according to a recent...
Among patients with early-stage cervical cancer, minimally invasive radical hysterectomy is associated with an elevated risk of recurrence and death compared with open radical hysterectomy, according to a recent...
Among...
06/23/2020
Journal of Clinical Pathways
News
Acalabrutinib Significantly Improves Survival in Relapsed, Refractory CLL
06/03/2020
Compared with two rituximab-containing regimens, acalabrutinib significantly improves progression-free survival (PFS) in patients with chronic lymphocytic leukemia (CLL) and has a comparable safety profile to these...
Compared with two rituximab-containing regimens, acalabrutinib significantly improves progression-free survival (PFS) in patients with chronic lymphocytic leukemia (CLL) and has a comparable safety profile to these...
...
06/03/2020
Journal of Clinical Pathways
News
Long-Term Follow-Up Data Supports Frontline Treatment Option for Older AML Patients
05/21/2020
Venetoclax plus low-dose cytarabine offers a clinically meaningful improvement in survival compared with placebo plus low-dose cytarabine in previously untreated older patients with acute myeloid leukemia (AML),...
Venetoclax plus low-dose cytarabine offers a clinically meaningful improvement in survival compared with placebo plus low-dose cytarabine in previously untreated older patients with acute myeloid leukemia (AML),...
...
05/21/2020
Journal of Clinical Pathways
Rapid Communication
Comparative Effectiveness of Two Collagen-containing Dressings: Oxidized Regenerated Cellulose (ORC)/Collagen/Silver-ORC Dressing Versus Ovine Collagen Extracellular Matrix
11/30/2019
Leah Griffin
Marissa J. Carter
Ralph D’Agostino
Lucy D’Agostino McGowan
This comparative effectiveness study evaluates the value proposition of 2 collagen-containing wound dressings — oxidized regenerated cellulose (ORC)/collagen/silver-ORC dressing and ovine collagen extracellular matrix (ECM) — in matched...
This comparative effectiveness study evaluates the value proposition of 2 collagen-containing wound dressings — oxidized regenerated cellulose (ORC)/collagen/silver-ORC dressing and ovine collagen extracellular matrix (ECM) — in matched...
This comparative effectiveness...
11/30/2019
Wounds
News
Breast Cancer Survival Outcomes After Mastectomy Versus Breast-Conserving Surgery
08/22/2017
JCP Editors
A recent comparative effectiveness study examined long-term survival outcomes for patients with multiple stages of breast cancer after undergoing either mastectomy or breast-conserving surgery, published in the...
A recent comparative effectiveness study examined long-term survival outcomes for patients with multiple stages of breast cancer after undergoing either mastectomy or breast-conserving surgery, published in the...
A...
08/22/2017
Journal of Clinical Pathways
Research in Review
Aggressive Local Therapy Improves Outcomes in Patients With Head and Neck Cancer
08/18/2017
JCP Editors
A recent study uncovered the benefits of adding high-intensity local treatment to systemic therapy for head and neck squamous cell carcinoma, published in Cancer (online August 17, 2017;...
A recent study uncovered the benefits of adding high-intensity local treatment to systemic therapy for head and neck squamous cell carcinoma, published in Cancer (online August 17, 2017;...
A...
08/18/2017
Journal of Clinical Pathways
Research in Review
Comparative Effectiveness Study Examines Treatment Options for DLBCL
08/18/2017
JCP Editors
A recent study compared the treatment effects and adverse events of first-line chemotherapy regimens in patients with treatment-naïve diffuse large B-cell lymphoma (DLBCL). Rituximab plus cyclophosphamide,...
A recent study compared the treatment effects and adverse events of first-line chemotherapy regimens in patients with treatment-naïve diffuse large B-cell lymphoma (DLBCL). Rituximab plus cyclophosphamide,...
A...
08/18/2017
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

November 23 ⁠–⁠ November 24
December 4 ⁠–⁠ December 5
Great Debates & Updates in Diabetic Foot
December 6 ⁠–⁠ December 7
AIBD
December 9 ⁠–⁠ December 11
December 9 ⁠–⁠ December 11
Psych Congress Primary Care Online Series
December 12 ⁠–⁠ December 13
December 14 ⁠–⁠ December 15
February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use